Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

A phenotype of IGFBP-3 knockout mice revealed by dextran sulfate-induced colitis.

Yancu D, Blouin MJ, Birman E, Florianova L, Aleynikova O, Zakikhani M, VanderMeulen H, Seidman E, Pollak M.

J Gastroenterol Hepatol. 2017 Jan;32(1):146-153. doi: 10.1111/jgh.13461.

PMID:
27253188
2.

Germ line knockout of IGFBP-3 reveals influences of the gene on mammary gland neoplasia.

Blouin MJ, Bazile M, Birman E, Zakikhani M, Florianova L, Aleynikova O, Powell DR, Pollak M.

Breast Cancer Res Treat. 2015 Feb;149(3):577-85. doi: 10.1007/s10549-015-3268-8. Epub 2015 Jan 23.

PMID:
25614235
3.

Serine deprivation enhances antineoplastic activity of biguanides.

Gravel SP, Hulea L, Toban N, Birman E, Blouin MJ, Zakikhani M, Zhao Y, Topisirovic I, St-Pierre J, Pollak M.

Cancer Res. 2014 Dec 15;74(24):7521-33. doi: 10.1158/0008-5472.CAN-14-2643-T. Epub 2014 Nov 6.

4.
5.

Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts.

Hvid H, Blouin MJ, Birman E, Damgaard J, Poulsen F, Fels JJ, Fledelius C, Hansen BF, Pollak M.

PLoS One. 2013 Nov 18;8(11):e79710. doi: 10.1371/journal.pone.0079710. eCollection 2013.

6.

Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization.

Hsieh J, Williams P, Rafei M, Birman E, Cuerquis J, Yuan S, Wu J, Galipeau J.

Mol Ther. 2012 Sep;20(9):1767-77. doi: 10.1038/mt.2012.127. Epub 2012 Jul 3.

7.

Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway.

Hvid H, Fendt SM, Blouin MJ, Birman E, Voisin G, Svendsen AM, Frank R, Vander Heiden MG, Stephanopoulos G, Hansen BF, Pollak M.

Endocr Relat Cancer. 2012 Jul 22;19(4):557-74. doi: 10.1530/ERC-12-0125. Print 2012 Aug.

PMID:
22685267
8.

Adoptive transfer of mesenchymal stromal cells accelerates intestinal epithelium recovery of irradiated mice in an interleukin-6-dependent manner.

François M, Birman E, Forner KA, Gaboury L, Galipeau J.

Cytotherapy. 2012 Nov;14(10):1164-70. doi: 10.3109/14653249.2012.684378. Epub 2012 May 10.

PMID:
22574720
9.

Metformin reduces endogenous reactive oxygen species and associated DNA damage.

Algire C, Moiseeva O, Deschênes-Simard X, Amrein L, Petruccelli L, Birman E, Viollet B, Ferbeyre G, Pollak MN.

Cancer Prev Res (Phila). 2012 Apr;5(4):536-43. doi: 10.1158/1940-6207.CAPR-11-0536. Epub 2012 Jan 18.

10.

B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-β receptor II induce potent antitumor immunity.

Penafuerte C, Ng S, Bautista-Lopez N, Birman E, Forner K, Galipeau J.

Cancer Res. 2012 Mar 1;72(5):1210-20. doi: 10.1158/0008-5472.CAN-11-1659. Epub 2012 Jan 12.

11.

IGF1/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer.

Dool CJ, Mashhedi H, Zakikhani M, David S, Zhao Y, Birman E, Carboni JM, Gottardis M, Blouin MJ, Pollak M.

Endocr Relat Cancer. 2011 Nov 14;18(6):699-709. doi: 10.1530/ERC-11-0136. Print 2011 Dec.

PMID:
21946410
12.

A MCP1 fusokine with CCR2-specific tumoricidal activity.

Rafei M, Deng J, Boivin MN, Williams P, Matulis SM, Yuan S, Birman E, Forner K, Yuan L, Castellino C, Boise LH, MacDonald TJ, Galipeau J.

Mol Cancer. 2011 Sep 24;10:121. doi: 10.1186/1476-4598-10-121.

13.

Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice.

Eliopoulos N, Zhao J, Forner K, Birman E, Young YK, Bouchentouf M.

Mol Ther. 2011 Nov;19(11):2072-83. doi: 10.1038/mt.2011.162. Epub 2011 Aug 16.

14.

Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet.

Mashhedi H, Blouin MJ, Zakikhani M, David S, Zhao Y, Bazile M, Birman E, Algire C, Aliaga A, Bedell BJ, Pollak M.

Cell Cycle. 2011 Aug 15;10(16):2770-8. Epub 2011 Aug 15.

PMID:
21811094
15.

Novel TGF-beta antagonist inhibits tumor growth and angiogenesis by inducing IL-2 receptor-driven STAT1 activation.

Penafuerte C, Bautista-Lopez N, Bouchentouf M, Birman E, Forner K, Galipeau J.

J Immunol. 2011 Jun 15;186(12):6933-44. doi: 10.4049/jimmunol.1003816. Epub 2011 May 6.

16.

A dendritic cell population generated by a fusion of GM-CSF and IL-21 induces tumor-antigen-specific immunity.

Williams P, Bouchentouf M, Rafei M, Romieu-Mourez R, Hsieh J, Boivin MN, Yuan S, Forner KA, Birman E, Galipeau J.

J Immunol. 2010 Dec 15;185(12):7358-66. doi: 10.4049/jimmunol.1002201. Epub 2010 Nov 12.

17.

Mesenchymal stromal cells expressing ErbB-2/neu elicit protective antibreast tumor immunity in vivo, which is paradoxically suppressed by IFN-gamma and tumor necrosis factor-alpha priming.

Romieu-Mourez R, François M, Abate A, Boivin MN, Birman E, Bailey D, Bramson JL, Forner K, Young YK, Medin JA, Galipeau J.

Cancer Res. 2010 Oct 15;70(20):7742-7. doi: 10.1158/0008-5472.CAN-10-0296. Epub 2010 Oct 5.

18.

Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.

Eliopoulos N, Zhao J, Bouchentouf M, Forner K, Birman E, Yuan S, Boivin MN, Martineau D.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1288-98. doi: 10.1152/ajprenal.00671.2009. Epub 2010 Sep 15.

19.

A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo.

Williams P, Rafei M, Bouchentouf M, Raven J, Yuan S, Cuerquis J, Forner KA, Birman E, Galipeau J.

Mol Ther. 2010 Jul;18(7):1293-301. doi: 10.1038/mt.2010.49. Epub 2010 Apr 13.

20.

Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo.

Bassili M, Birman E, Schor NF, Saragovi HU.

Cancer Chemother Pharmacol. 2010 May;65(6):1047-56. doi: 10.1007/s00280-009-1110-x. Epub 2009 Aug 22.

21.

A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties.

Rafei M, Hsieh J, Zehntner S, Li M, Forner K, Birman E, Boivin MN, Young YK, Perreault C, Galipeau J.

Nat Med. 2009 Sep;15(9):1038-45. doi: 10.1038/nm.2003. Epub 2009 Aug 9.

PMID:
19668193
22.

Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.

Rafei M, Birman E, Forner K, Galipeau J.

Mol Ther. 2009 Oct;17(10):1799-803. doi: 10.1038/mt.2009.157. Epub 2009 Jul 14.

23.

An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.

Rafei M, Berchiche YA, Birman E, Boivin MN, Young YK, Wu JH, Heveker N, Galipeau J.

J Immunol. 2009 Aug 1;183(3):1759-66. doi: 10.4049/jimmunol.0900523. Epub 2009 Jul 10.

24.

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.

Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J.

J Immunol. 2009 May 15;182(10):5994-6002. doi: 10.4049/jimmunol.0803962.

25.

Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine.

Rafei M, Campeau PM, Wu JH, Birman E, Forner K, Boivin MN, Galipeau J.

J Immunol. 2009 Mar 1;182(5):2620-7. doi: 10.4049/jimmunol.0803495.

26.

Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.

Campeau PM, Rafei M, François M, Birman E, Forner KA, Galipeau J.

Mol Ther. 2009 Feb;17(2):369-72. doi: 10.1038/mt.2008.270. Epub 2008 Dec 16.

27.

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

Rafei M, Hsieh J, Fortier S, Li M, Yuan S, Birman E, Forner K, Boivin MN, Doody K, Tremblay M, Annabi B, Galipeau J.

Blood. 2008 Dec 15;112(13):4991-8. doi: 10.1182/blood-2008-07-166892. Epub 2008 Sep 23.

PMID:
18812467
28.

Alpha2-macroglobulin is a mediator of retinal ganglion cell death in glaucoma.

Shi Z, Rudzinski M, Meerovitch K, Lebrun-Julien F, Birman E, Di Polo A, Saragovi HU.

J Biol Chem. 2008 Oct 24;283(43):29156-65. doi: 10.1074/jbc.M802365200. Epub 2008 Aug 13.

29.

Burning mouth syndrome: clinical profile of Brazilian patients and oral carriage of Candida species.

Cavalcanti DR, Birman EG, Migliari DA, da Silveira FR.

Braz Dent J. 2007;18(4):341-5.

30.

Erythematous candidosis in patients with complete dentures and HIV+/AIDS.

Aleva NA, Birman EG, Afonso W Jr, Chavasco JK, Paula CR, Ribeiro A, Pereira LJ.

Mycoses. 2007 Sep;50(5):407-11.

PMID:
17714362
31.

Candida albicans: Frequency and characterization in oral cancer (Stage I) from smokers and drinkers.

Birman EG, Kignel S, Da Silveira FR, Paula CR.

Rev Iberoam Micol. 1997 Sep;14(3):101-3.

32.

Candida isolated from vaginal mucosa of mothers and oral mucosa of neonates: occurrence and biotypes concordance.

Caramalac DA, da Silva Ruiz L, de Batista GC, Birman EG, Duarte M, Hahn R, Paula CR.

Pediatr Infect Dis J. 2007 Jul;26(7):553-7.

PMID:
17596793
33.

Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo.

Shi Z, Birman E, Saragovi HU.

Dev Neurobiol. 2007 Jun;67(7):884-94. Erratum in: Dev Neurobiol. 2007 Sep 15;67(11):1547-8.

34.

Ultrasonographic findings in normal temporomandibular joints.

Elias FM, Birman EG, Matsuda CK, Oliveira IR, Jorge WA.

Braz Oral Res. 2006 Jan-Mar;20(1):25-32. Epub 2006 May 22.

35.

Occurrence of Helicobacter pylori in dental plaque and saliva of dyspeptic patients.

Kignel S, de Almeida Pina F, André EA, Alves Mayer MP, Birman EG.

Oral Dis. 2005 Jan;11(1):17-21.

PMID:
15641962
36.

Hypermethylation of the p16 gene in normal oral mucosa of smokers.

von Zeidler SV, Miracca EC, Nagai MA, Birman EG.

Int J Mol Med. 2004 Nov;14(5):807-11.

PMID:
15492849
37.

Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.

Migliorati CA, Birman EG, Cury AE.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):301-10.

PMID:
15356467
38.

Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance.

Bosco VL, Birman EG, Cury AE, Paula CR.

Pesqui Odontol Bras. 2003 Jul-Sep;17(3):217-22. Epub 2003 Dec 16.

PMID:
14762498
39.

Ultrasonography of the temporomandibular joint: where is the disc?

Elias FM, Birman EG, Jorge WA, Homsi C.

J Oral Maxillofac Surg. 2002 Nov;60(11):1381. No abstract available.

PMID:
12420281
40.

Oral manifestations in children with AIDS and in controls.

Bosco VL, Birman EG.

Pesqui Odontol Bras. 2002 Jan-Mar;16(1):7-11. Epub 2002 Jun 21.

PMID:
11938722
41.

Relation of oral yeast infection in Brazilian infants and use of a pacifier.

Mattos-Graner RO, de Moraes AB, Rontani RM, Birman EG.

ASDC J Dent Child. 2001 Jan-Feb;68(1):33-6, 10.

PMID:
11324404
42.

Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways.

Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E, Laor N, Rauchverger B, Kreinin A, Poyurovsky M, Schneidman M, Modai I, Weizman R.

Mol Psychiatry. 1999 Jul;4(4):389-92.

PMID:
10483058
43.

Natal teeth: review of the literature and report of an unusual case.

Gonçalves FA, Birman EG, Sugaya NN, Melo AM.

Braz Dent J. 1998;9(1):53-6. Review.

PMID:
9835805
44.

Oral findings in pediatric AIDS: a case control study in Brazilian children.

Costa LR, Villena RS, Sucasas PS, Birman EG.

ASDC J Dent Child. 1998 May-Jun;65(3):186-90.

PMID:
9668947
45.

Oral manifestations in Rett syndrome: a study of 17 cases.

Ribeiro RA, Romano AR, Birman EG, Mayer MP.

Pediatr Dent. 1997 Jul-Aug;19(5):349-52.

PMID:
9260231
46.

Oral manifestations of diabetes mellitus in controlled and uncontrolled patients.

Quirino MR, Birman EG, Paula CR.

Braz Dent J. 1995;6(2):131-6.

PMID:
8688658
47.

Human papilloma virus--its association with epithelial proliferative lesions.

Costa LJ, Silveira FR, Batista JM, Birman EG.

Braz Dent J. 1994;5(1):5-10. Review.

PMID:
7833642
48.

Oral yeasts in patients with cancer of the mouth, before and during radiotherapy.

Paula CR, Sampaio MC, Birman EG, Siqueira AM.

Mycopathologia. 1990 Nov;112(2):119-24.

PMID:
2293033
50.

[Evaluation of the histocompatibility of endodontic cement in subcutaneous connective tissue using three methods].

Ferraz SL, Birman EG, Antoniazzi JH, Magalhães J.

Rev Odontol Univ Sao Paulo. 1990 Jul-Sep;4(3):241-6. Portuguese.

PMID:
2135431

Supplemental Content

Loading ...
Support Center